Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
We're a long way from 2020, when Cathie Wood turned heads as the co-founder CEO of the Ark Invest family of exchange-traded funds (ETFs). Most of the Ark funds more than doubled that year, only to fall sharply in 2021 and 2022. Wood is beating the market again in 2023, but there's been a little turbulence this summer.
Thankfully for Wood, she doesn't mind the volatility. She's often adding to some of her largest positions when they take a step back. She added to her existing stakes in Palantir Technologies (NYSE: PLTR), Teladoc Health (NYSE: TDOC), and Ginkgo Bioworks (NYSE: DNA) on Thursday. Let's take a closer look.
Shares of Palantir have taken a 31% hit since hitting a 52-week high last month, including a 5% decline on Thursday. Wood is feeling opportunistic. She bought more than 1 million shares of the software builder for the intelligence community on Thursday.
Source Fool.com
